HTLV Detection Kits and Automated Systems
HTLV Technical Information
Contact Us For More Information

Events Calendar

Jul 31

IAFP 2016

Jul 31, 2016

Booth #704 St. Louis, MO

Aug 28

DIOXIN 2016

Aug 28, 2016

Firenze, Italy

Sep 12

IOBC 2016

Sep 12, 2016

Berlin, Germany

Screening Algorithm

AABB recommends the dual enzyme immuno assay (EIA) approach for deferral and notification of Anti-HTLV-I/II EIA reactive donors. The #99-9 bulletin listed by the AABB and 21CFR 640.10.e clearly states that reactive unit should be further tested whenever a supplemental (additional, more specific) test has been approved for such use by FDA.

Dual Enzyme EIA Algorithm

References:
AABB Institutional Bulletin 9/1/1999: Dual Enzyme Immuno Assay (EIA) Approach for Deferral and Notification of Anti-HTLV-I/II EIA Reactive Donors
HTLV-I Antibody Testing
Guidance for Industry: Donor Screening for Antibodies to HTLV-II
Stramer et. al. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004. Transfusion Complications. 2006; 46:703-707
Disclaimer Notice
The health information contained herein is provided for educational, reference purposes only, and is not intended to substitute professional medical advice, diagnosis, or treatment with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. Please check the availability and relevance of the information in your respective country.